First Eagle Investment Management’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

First Eagle Investment Management’s Portfolio KBIO Stock Details KBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-218,324	Closed	-$3.02M	–	370
2014 Q4	$3.02M	Hold	218,324	–	–	0.01%	196
2014 Q3	$2.71M	Hold	218,324	–	–	0.01%	205
2014 Q2	$3.98M	Hold	218,324	–	–	0.01%	195
2014 Q1	$4.73M	Buy	218,324 +108,949	+100%	+$3.16M	0.01%	166
2013 Q4	$3.87M	Hold	109,375	–	–	0.01%	176
2013 Q3	$3.96M	Buy	+109,375	New	+$4.98M	0.01%	186

Other funds holding KBIO

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OPPM

Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

OWIM

Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

First Eagle Investment Management's KBIO Position: Q1 2015 in Review

First Eagle Investment Management sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2015, closing a stake of 218,324 shares — an estimated $3.02M sold.

First Eagle Investment Management first reported a position in KBIO in Q3 2013 and held it in 6 quarters. The position peaked at $4.73M in Q1 2014. 24 funds tracked by Wall St. Rank hold KBIO as of Q1 2015.

First Eagle Investment Management reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2015 after selling out during the quarter.
First Eagle Investment Management sold 218,324 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2015, an estimated $3.02M.
First Eagle Investment Management first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q3 2013 and held it in 6 quarters.
First Eagle Investment Management's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $4.73M in Q1 2014.
24 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2015.

Based on First Eagle Investment Management's 13F filing for Q1 2015, filed 7 May 2015.